Table 2.
Metabolites significantly different (p-value < 0.05) when comparing high vs. low IL-13 patient metabolomics
| COVID-19 Status | IL-13 Level | Enriched Metabolite |
|---|---|---|
| Severe | High | 4-imidazolone-5-propanoate |
| 3-methylglutarylcarnitine | ||
| Non-Acute | High | L-homocysteic acid |
| Low | (24R,24'R)-fucosterol epoxide alanyl-poly(glycerolphosphate) | |
| Erucamide | ||
| L-Ascorbate 6-phosphate | ||
| N2-acetyl-L-lysine | ||
| 11-Nitro-1-undecane | ||
| β –leucine | ||
| n-ribosylhistidine | ||
| Trp-Phe | ||
| trimethylsilyl N,O-bis(trimethylsilyl)serinate |